The detailed information for PTAB case with proceeding number IPR2019-01095 filed by Mylan Pharmaceuticals Inc. et al. against Almirall, LLC on Jun 7, 2019. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2019-01095
Filing Date
Jun 7, 2019
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Almirall, LLC
Status
Final Written Decision
Respondent Application Number
14885805
Respondent Tech Center
1600
Respondent Patent Number
9517219
Institution Decision Date
Nov 27, 2019
Termination Date
May 29, 2020

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Other: fed circuit mandate

Sep 16, 2022PAPERBOARD

Other: other court decision

Sep 16, 2022PAPERBOARD

Trial Certificate Checklist

Sep 16, 2022PAPERBOARD

Petitioner Mylan Pharmaceutical Inc's First Updated Mandatory Notice

Dec 2, 2020PAPERPETITIONER

CONDUCT OF THE PROCEEDING Expunging Unauthorized New Evidence 37 C.F.R. ¿¿ 42.7

Aug 20, 2020PAPERBOARD

Termination Decision Document

May 29, 2020PAPERBOARD

Trial Instituted Document

Nov 27, 2019PAPERBOARD

Petitioners Reply

Oct 14, 2019PAPERPETITIONER

ORDER Authorizing Reply to Preliminary Response to Petitioner and Sur-reply to Patent Owner 37 C.F.R. ¿¿ 42.108(c)

Oct 7, 2019PAPERBOARD

Patent Owner's Preliminary Response

Sep 10, 2019PAPERPATENT OWNER

Exhibit 2001 - Declaration of Elizabeth B. Hagan in Support of Patent Owner Almirall, LLC's Motion for Admission Pro Hac Vice

Jul 2, 2019EXHIBITPATENT OWNER

Patent Owner Almirall, LLC's Motion for Pro Hac Vice Admission of Elizabeth B. Hagan Pursuant to 37 C.F.R. Section 42.10(c)

Jul 2, 2019PAPERPATENT OWNER

Patent Owner Almirall, LLC's Mandatory Notices Under 37 C.F.R. Section 42.10(b)

Jun 28, 2019PAPERPATENT OWNER

Patent Owner Almirall, LLC's Power of Attorney

Jun 28, 2019PAPERPATENT OWNER

Notice of Accord Filing Date

Jun 10, 2019PAPERBOARD

U.S. Patent No. 9,517,219

Jun 7, 2019EXHIBITPETITIONER

Declaration of Bozena B. Michniak-Kohn, Ph.D., FAAPS, M.R.Pharm.S.

Jun 7, 2019EXHIBITPETITIONER

International Patent Application Publication No. WO 2009/061298 ("Garrett")

Jun 7, 2019EXHIBITPETITIONER

U.S. Patent Publication No. 2006/0204526 ("Lathrop")

Jun 7, 2019EXHIBITPETITIONER

U.S. Patent Publication No. 2010/0029781 ("Morris")

Jun 7, 2019EXHIBITPETITIONER

Physician's Desk Reference, 65th ed., pp. 599-602 (2011) (ACZONE Gel 5% Label)

Jun 7, 2019EXHIBITPETITIONER

U.S. Patent No. 7,820,186 ("Orsoni")

Jun 7, 2019EXHIBITPETITIONER

Epiduo Product Label, approved December 8, 2008 ("Epiduo Label")

Jun 7, 2019EXHIBITPETITIONER

U.S. Patent Publication No. 2007/0190019 ("Guo")

Jun 7, 2019EXHIBITPETITIONER

Curriculum Vitae for Bozena B. Michniak-Kohn, Ph.D., FAAPS, M.R.Pharm.S.

Jun 7, 2019EXHIBITPETITIONER

International Application Publication No. WO 2010/072958 ("Nadau-Fourcade")

Jun 7, 2019EXHIBITPETITIONER

Certification for Translation of WO 2010/072958

Jun 7, 2019EXHIBITPETITIONER

Osborne, D.W., "Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products," J. Cosmetic Derm. 10:324-329 (2011) ("Osborne I")

Jun 7, 2019EXHIBITPETITIONER

Rowe, R.C. et al. (Eds.), Handbook of Pharmaceutical Excipients, 6th Ed., Pharmaceutical Press: London, UK (2009)

Jun 7, 2019EXHIBITPETITIONER

Bonacucina, G., et al., "Characterization and Stability of Emulsion Gels Based on Acrylamide/Sodium Acryloyldimethyl Taurate Copolymer," AAPS PharmaSciTech 10:368-375 (2009) ("Bonacucina")

Jun 7, 2019EXHIBITPETITIONER

U.S. Patent No. 5,863,560 ("Osborne II")

Jun 7, 2019EXHIBITPETITIONER

Declaration of Elaine S. Gilmore, M.D., Ph.D.

Jun 7, 2019EXHIBITPETITIONER

Affidavit of Christopher Butler

Jun 7, 2019EXHIBITPETITIONER

Wozel, D., "Innovative Use of Dapsone" Dermatol. Clin. 28: 599- 610 (2010) ("Wozel")

Jun 7, 2019EXHIBITPETITIONER

Nguyen, R. and Su, J., "Treatment of Acne Vulgaris" Pediatrics and Child Health 21: 119-125 (2010) ("Nguyen")

Jun 7, 2019EXHIBITPETITIONER

Remington: The Science and Practice of Pharmacy, 21st Ed., Lippincott Williams & Wilkins: Baltimore, MD (2005) ("Remington")

Jun 7, 2019EXHIBITPETITIONER

Spain's Almirall bets on dermatology with $650 million U.S. deal, Retrieved from https://www.reuters.com/article/us-allergan-m-a- almirall/spains-almirall-bets-on-dermatology-with-650-million-us- deal-idUSKBN1KO10N, last accessed October 26, 2018

Jun 7, 2019EXHIBITPETITIONER

Piskin, S. et al. "A review of the use of adapalene for the treatment of acne vulgaris," Therapeutics and Clinical Risk Management 3(4): 621-624 (2007) ("Piskin")

Jun 7, 2019EXHIBITPETITIONER

Andersson, D., "Evonik-Degussa expands its cooperation with Alsiano," Pharma & Healthcare News : 1-10 (2007)

Jun 7, 2019EXHIBITPETITIONER

Curriculum Vitae for Audra L. Stinchcomb, Ph.D.

Jun 7, 2019EXHIBITPETITIONER

Curriculum Vitae for Elaine S. Gilmore, M.D., Ph.D.

Jun 7, 2019EXHIBITPETITIONER

Thiboutot, D., et al., "Pharmacokinetics of Dapsone Gel, 5% for the Treatment of Acne Vulgaris" Clin. Pharmacokinet. 46: 697- 712 (2007) ("Thiboutot")

Jun 7, 2019EXHIBITPETITIONER

Williams, H., et al., "Acne vulgaris" Lancet 379: 361-72 (2012) ("Williams")

Jun 7, 2019EXHIBITPETITIONER

SepineoTM P 600 Brochure

Jun 7, 2019EXHIBITPETITIONER

Barclay, L., "Use of Topical Corticosteroids for Dermatologic Conditions Reviewed" Medscape - Jan 21, 2009, accessed from https://www.medscape.com/viewarticle/587159_print ("Barclay")

Jun 7, 2019EXHIBITPETITIONER

Kim, J-Y., et al., "Rheological properties and microstructures of Carbopol gel network system," Colloid. Polym. Sci. 281:614- 623(2003) ("Kim")

Jun 7, 2019EXHIBITPETITIONER

Declaration of Audra L. Stinchcomb, Ph.D.

Jun 7, 2019EXHIBITPETITIONER

Petition for Inter Partes Review of U.S. Patent No. 9,517,219 Under 35 U.S.C. 311-319 AND 37 C.F.R. 42.1-.80, 42.100-.123

Jun 7, 2019PAPERPETITIONER

Exhibit List

Jun 7, 2019PAPERPETITIONER

POA

Jun 7, 2019PAPERPETITIONER

Declaration of Marc Serota, M.D.

Jun 7, 2019EXHIBITPETITIONER

Curriculum Vitae for Marc Serota, M.D.

Jun 7, 2019EXHIBITPETITIONER

File History of U.S. Patent No. 9,517,219

Jun 7, 2019EXHIBITPETITIONER

Petitioner's Motion For Joinder Under 37 C.F.R. 42.22 AND 42.122(b)

Jun 7, 2019PAPERPETITIONER